Cargando…
Novel Genetically Engineered Probiotics for Targeted Elimination of Pseudomonas aeruginosa in Intestinal Colonization
The intestinal carriage rates of Pseudomonas aeruginosa are notably elevated in immunosuppressed individuals and hospitalized patients, increasing the risk of infection and antibiotic-associated diarrhea. A potential solution to this issue lies in autonomous antibacterial therapy, remaining inactive...
Autores principales: | Kim, Hyun, Jang, Ju Hye, Jung, In Young, Kim, Ha Rang, Cho, Ju Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604247/ https://www.ncbi.nlm.nih.gov/pubmed/37893018 http://dx.doi.org/10.3390/biomedicines11102645 |
Ejemplares similares
-
Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
por: Hwang, In Young, et al.
Publicado: (2017) -
Pseudomonas aeruginosa Eliminates Natural Killer Cells via Phagocytosis-Induced Apoptosis
por: Chung, Jin Woong, et al.
Publicado: (2009) -
Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa
por: Cho, Hye Hyun, et al.
Publicado: (2014) -
Reverse Genetic Systems for Pseudomonas aeruginosa Leviphages
por: Lee, Jae-Yeol, et al.
Publicado: (2019) -
An antipathogenic compound that targets the OxyR peroxide sensor in Pseudomonas aeruginosa
por: Oh, Hyo-Young, et al.
Publicado: (2021)